Abstract
Abstract
Background
Despite their rarity, malignant odontogenic tumors (MOT) represent an important group of oral lesions characterized by their variable clinical presentations and sometimes unexpected biological behavior.
Objectives
The purpose of this retrospective cross-sectional study was to evaluate the number, types, and frequency of MOT and to investigate the relative rate of malignant transformation in recurrent odontogenic tumors (OT).
Methodology
The records of patients diagnosed with OT in the hospital of the Faculty of Dentistry, Cairo University, were reviewed over 10 years (2013-2022). The OT were investigated for frequency, age, gender, site, and recurrence. The data were recorded and then analyzed using SPSS software version 25.
Results
Among 5543 oral excisions, 357 cases of them were OT, including 336 benign (94.1%) and 21 malignant neoplasms (5.9%). Among the odontogenic malignancies, 18 lesions (85.7%) appeared de novo, and 3 lesions (14.3%) developed as recurrent of previously classified benign tumors. A high incidence was observed in the middle and old age groups (90.4%) with a median age being 42. Slight male predilection (1.3:1) was noticed. The mandible was the highly affected site but all recurrent cases were diagnosed in the maxilla as ghost cell odontogenic carcinoma (n = 2, 66.6%) and primary intraosseous carcinoma (n = 1, 33.3%).
Conclusion
Retrospective analysis of the relative frequency of MOT and the documentation of the unusual recurrence of benign OT as a malignancy enhances our understanding of OT behavior and the need for appropriate therapy and clinical follow-up.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Villegas KM, Paparella ML (2022) Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature. Oral Oncol 134:1060–1068
2. Mascitti M, Togni L, Troiano G, Caponio VC, Sabatucci A, Balercia A, Rubini C, Lo Muzio L, Santarelli A (2020) Odontogenic tumours: a 25-year epidemiological study in the Marche region of Italy. Eur Arch Oto-Rhino-L 277:527–538
3. Soluk-Tekkesin M, Wright JM (2022) The world health organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition. Turk Patoloji Derg 38(2):168–184
4. Yilmaz O, Sagnak-Yilmaz Z, Balaban E, Candirli C (2020) Management of recurrence of ameloblastoma and odontogenic keratocyst: a cross-sectional study. Odovtos 22:3
5. Vered M, Wright JM (2022) Update from the 5th edition of the world health organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol 16(1):63–75